Document is current
Any future updates will be listed below
-
Authors
Zuern, Kosima https://orcid.org/0009-0006-9688-3697
Hielscher, Thomas
Werly, Annika
Breitkreutz, Iris
Sauer, Sandra https://orcid.org/0000-0001-5552-3149
Raab, Marc S. https://orcid.org/0000-0003-4181-6922
Müller-Tidow, Carsten
Goldschmidt, Hartmut https://orcid.org/0000-0003-0961-0035
Mai, Elias K. https://orcid.org/0000-0002-6226-1252
-
Funding
Funding for this research was provided by:
Dietmar-Hopp Foundation
- License Information
-
More Information
Article History
Received: 14 May 2024
Revised: 7 August 2024
Accepted: 12 August 2024
First Online: 27 August 2024
Competing interests
: MSR reports consulting or advisory role with BMS, Amgen, GSK, Janssen, Sanofi, Pfizer, AbbVie, and Takeda; research funding from BMS, Janssen, Sanofi, and Heidelberg Pharma; travel accommodation and expenses from BMS, Amgen, and Janssen; and honoraria from BMS, Janssen, AbbVie, and Sanofi. HG reports consulting or advisory role with Amgen, BMS, Janssen, Sanofi, and Adaptive Biotechnology; honoraria from Amgen, BMS, Chugai, GlaxoSmithKline, Janssen, Novartis, Sanofi, and Pfizer; research funding from Amgen, BMS, Celgene, GlycoMimetics Inc., GlaxoSmithKline, Heidelberg Pharma, Hoffmann-La Roche, Karyopharm, Janssen, Incyte Corporation, Millenium Pharmaceuticals Inc., Molecular Partners, Merck Sharp and Dohme, MorphoSys AG, Pfizer, Sanofi, Takeda, and Novartis; travel accommodations and expenses from Amgen, BMS, GlaxoSmithKline, Janssen, Novartis, Sanofi, and Pfizer; grants from Amgen, Array Biopharma/Pfizer, BMS/Celgene, Chugai, Dietmar-Hopp-Foundation, Janssen, Johns Hopkins University, Mundipharma GmbH, and Sanofi. EKM reports consulting or advisory role with Amgen, BMS/Celgene, GlaxoSmithKline, Janssen-Cilag, Pfizer, Sanofi, Stemline, and Takeda; honoraria from Amgen, BMS/Celgene, GlaxoSmithKline, Janssen-Cilag, Pfizer, Sanofi, Stemline, and Takeda; research funding from BMS/Celgene, GlaxoSmithKline, Janssen-Cilag, Sanofi, and Takeda; and travel accommodations and expenses from BMS/Celgene, GlaxoSmithKline, Janssen-Cilag, Sanofi, Stemline, and Takeda.
